Literature DB >> 2322516

Risk factors for proliferative sickle retinopathy.

P D Fox1, D T Dunn, J S Morris, G R Serjeant.   

Abstract

The prevalence, incidence, and risk factors associated with proliferative sickle retinopathy (PSR) were investigated in 786 patients with homozygous sickle cell (SS) disease and 533 patients with sickle cell haemoglobin C (SC) disease. PSR was more common in SC disease, in which there was a significant predominance of males, and it increased with age in both genotypes. In SC disease the risk of developing PSR was highest between 15 and 24 years in males, between 20 and 39 years in females, and in SS disease between 25 and 39 years in both sexes. PSR tended to be bilateral, especially in SC disease. There was no evidence of familial clustering of PSR in SC siblings, and insufficient numbers of SS siblings were available to test for clustering. Haematological risk factors associated with PSR in SS disease were a high haemoglobin in males and a low fetal haemoglobin in both sexes and in SC disease, a high mean cell volume, and a low fetal haemoglobin in females.

Entities:  

Mesh:

Year:  1990        PMID: 2322516      PMCID: PMC1042042          DOI: 10.1136/bjo.74.3.172

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Improved rapid methods for the determination of iron content and binding capacity of serum.

Authors:  R N BEALE; J O BOSTROM; R F TAYLOR
Journal:  J Clin Pathol       Date:  1962-03       Impact factor: 3.411

2.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

3.  Factors affecting the rate of coupling of bilirubin and conjugated bilirubin in the van de Bergh reaction.

Authors:  G H LATHE; C R RUTHVEN
Journal:  J Clin Pathol       Date:  1958-03       Impact factor: 3.411

4.  Spontaneous remodeling of the peripheral retinal vasculature in sickling disorders.

Authors:  S O Galinos; G K Asdourian; M B Woolf; T S Stevens; C B Lee; M F Goldberg; J C Chow; B J Busse
Journal:  Am J Ophthalmol       Date:  1975-05       Impact factor: 5.258

5.  Screening cord bloods for detection of sickle cell disease in Jamaica.

Authors:  B E Serjeant; M Forbes; L L Williams; G R Serjeant
Journal:  Clin Chem       Date:  1974-06       Impact factor: 8.327

6.  Irreversibly sickled cells and splenomegaly in sickle-cell anaemia.

Authors:  G R Serjeant
Journal:  Br J Haematol       Date:  1970-11       Impact factor: 6.998

7.  Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease.

Authors:  R J Hayes; P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

8.  Haematological factors associated with proliferative retinopathy in sickle cell-haemoglobin C disease.

Authors:  R J Hayes; P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1981-10       Impact factor: 4.638

9.  Behaviour of untreated proliferative sickle retinopathy.

Authors:  P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1980-06       Impact factor: 4.638

10.  Sickle cell retinopathy in Jamaican children: a search for prognostic factors.

Authors:  J F Talbot; A C Bird; L M Rabb; G H Maude; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

View more
  16 in total

Review 1.  New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Royce W S Chen
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

2.  Multifocal electroretinogram findings in sickle cell maculopathy.

Authors:  Laurence Beral; Marc Romana; Nathalie Lemonne; Yoann Garnier; Marie Billaud; Malik Acomat; Coralie Zorobabel; Maryse Etienne-Julan; Thierry David; Philippe Connes
Journal:  Eye (Lond)       Date:  2019-07-09       Impact factor: 3.775

3.  New classification of peripheral retinal vascular changes in sickle cell disease.

Authors:  A D Penman; J F Talbot; E L Chuang; P Thomas; G R Serjeant; A C Bird
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

4.  Incidence of eye complications among sickle cell disease patients in Jeddah, Saudi Arabia: A cross-sectional study.

Authors:  Eid Ayed Almasoudi; Sultan Fahad Magliah; Abubakr Salem Alzwaihri; Abdullah Omar Aljuwaybiri; Abdullah Saleh Alqahtani
Journal:  Ann Med Surg (Lond)       Date:  2022-06-21

5.  Analysis of Retinal Thinning Using Spectral-domain Optical Coherence Tomography Imaging of Sickle Cell Retinopathy Eyes Compared to Age- and Race-Matched Control Eyes.

Authors:  Jennifer I Lim; Dingcai Cao
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

6.  Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia.

Authors:  Clément Lemaire; Yann Lamarre; Nathalie Lemonne; Xavier Waltz; Sadri Chahed; Florence Cabot; Ioana Botez; Benoit Tressieres; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2013-01-01       Impact factor: 2.375

Review 7.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

8.  Monitoring retinal pathology and cerebral injury in sickle cell disease using spectral-domain optical coherence tomography in pediatric patients.

Authors:  Jing Jin; Vinay Kandula; Robin E Miller
Journal:  Pediatr Blood Cancer       Date:  2021-03-31       Impact factor: 3.838

9.  An eye on sickle cell retinopathy.

Authors:  Mônica Barbosa de Melo
Journal:  Rev Bras Hematol Hemoter       Date:  2014-08-12

10.  Sickle cell disease retinopathy: characterization among pediatric and teenage patients from northeastern Brazil.

Authors:  Dayse Cury de Almeida Oliveira; Magda O S Carvalho; Valma Maria Lopes do Nascimento; Flávia Silva Villas-Bôas; Bernardo Galvão-Castro; Marilda Souza Goncalves
Journal:  Rev Bras Hematol Hemoter       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.